25年瘤遗传学的见解:一个人的观点
1The Suzanne Levy Gertner Oncogenetics Unit, The Meirav High Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Frontiers in genetics
|May 30, 2023
概括
瘤遗传学已经发展成为个性化癌症预防的关键领域. 这次旅程强调了遗传性癌症风险的个人的基因测试,咨询和监测方面的进展.
科学领域:
- 医学遗传学 医学遗传学
- 在瘤学瘤学.
- 预防医学 预防医学
背景情况:
- 1995年在谢巴医疗中心建立了瘤遗传学服务.
- 瘤遗传学已经从一个利基服务转变为癌症护理的关键组成部分.
研究的目的:
- 详细介绍以色列瘤遗传学的演变和挑战.
- 讨论医生和公众意识,道德考虑和咨询指南.
- 探索遗传性癌症遗传检测和监测策略的发展.
主要方法:
- 对瘤遗传学服务发展的个人反思.
- 分析关键问题,包括意识,道德,法律方面和测试.
- 对转变载体的咨询和监测指南的审查.
主要成果:
- 通过基因识别实现个性化预防医学的重大进展.
- 成功实施早期检测和降低风险的战略.
- 在以色列人口中开发BRCA1和BRCA2突变的特定方法.
结论:
- 瘤遗传学是个性化预防医学的一个成功模式.
- 持续的挑战包括公众意识,道德框架和指导方针的实施.
- 未来的方向包括完善监视和扩大瘤遗传学服务的范围.
相关概念视频
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Cancers Originate from Somatic Mutations in a Single Cell
12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402


